ISCHEMIC CARDIOMYOPATHY
Clinical trials for ISCHEMIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new ISCHEMIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for ISCHEMIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stents plus drugs vs. drugs alone: which is better for heart failure?
Disease control Not yet recruitingThis study compares two approaches for people with heart failure and narrowed heart arteries: a stent procedure plus guideline-directed medications versus medications alone. About 1,150 participants will be followed for at least two years to see which group has fewer major heart …
Matched conditions: ISCHEMIC CARDIOMYOPATHY
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Engineered immune cells aim to repair damaged hearts
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy for people with heart failure caused by blocked arteries. The treatment uses the patient's own immune cells, engineered to target scar tissue in the heart. The study will check safety and whether it can improve heart function in 15 …
Matched conditions: ISCHEMIC CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC